Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 18701488)

1.

Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation.

Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, Zhang W, Bailey R, Maric D, Zenklusen JC, Lee J, Fine HA.

Cancer Res. 2008 Aug 15;68(16):6643-51. doi: 10.1158/0008-5472.CAN-08-0850.

2.

Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells.

Marchand B, Arsenault D, Raymond-Fleury A, Boisvert FM, Boucher MJ.

J Biol Chem. 2015 Feb 27;290(9):5592-605. doi: 10.1074/jbc.M114.616714. Epub 2015 Jan 5.

PMID:
25561726
3.

Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.

Rahmani M, Aust MM, Attkisson E, Williams DC Jr, Ferreira-Gonzalez A, Grant S.

Cancer Res. 2013 Feb 15;73(4):1340-51. doi: 10.1158/0008-5472.CAN-12-1365. Epub 2012 Dec 12.

4.
5.

Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.

Pyko IV, Nakada M, Sabit H, Teng L, Furuyama N, Hayashi Y, Kawakami K, Minamoto T, Fedulau AS, Hamada J.

Carcinogenesis. 2013 Oct;34(10):2206-17. doi: 10.1093/carcin/bgt182. Epub 2013 May 28.

6.

Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.

Dokken BB, Sloniger JA, Henriksen EJ.

Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1188-94. Epub 2005 Jan 25.

8.

Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms.

Marchand B, Tremblay I, Cagnol S, Boucher MJ.

Carcinogenesis. 2012 Mar;33(3):529-37. doi: 10.1093/carcin/bgr309. Epub 2011 Dec 26.

9.

Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth.

Dudgeon C, Peng R, Wang P, Sebastiani A, Yu J, Zhang L.

Oncogene. 2012 Nov 15;31(46):4848-58. doi: 10.1038/onc.2011.644. Epub 2012 Jan 30.

10.

CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells.

Kim HM, Kim CS, Lee JH, Jang SJ, Hwang JJ, Ro S, Choi J.

PLoS One. 2013;8(4):e60383. doi: 10.1371/journal.pone.0060383. Epub 2013 Apr 2.

11.

Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.

Bangert A, Cristofanon S, Eckhardt I, Abhari BA, Kolodziej S, Häcker S, Vellanki SH, Lausen J, Debatin KM, Fulda S.

Oncogene. 2012 Nov 1;31(44):4677-88. doi: 10.1038/onc.2011.614. Epub 2012 Jan 23.

PMID:
22266862
12.
13.

GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption.

Watcharasit P, Thiantanawat A, Satayavivad J.

J Appl Toxicol. 2008 May;28(4):466-74.

PMID:
17849503
14.
15.

Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.

Koul D, Shen R, Bergh S, Lu Y, de Groot JF, Liu TJ, Mills GB, Yung WK.

Mol Cancer Ther. 2005 Nov;4(11):1681-8.

16.

Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis.

Gupta P, Dixit D, Sen E.

Carcinogenesis. 2013 Feb;34(2):388-96. doi: 10.1093/carcin/bgs352. Epub 2012 Nov 3.

17.

Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.

Tang QL, Xie XB, Wang J, Chen Q, Han AJ, Zou CY, Yin JQ, Liu DW, Liang Y, Zhao ZQ, Yong BC, Zhang RH, Feng QS, Deng WG, Zhu XF, Zhou BP, Zeng YX, Shen JN, Kang T.

J Natl Cancer Inst. 2012 May 16;104(10):749-63. doi: 10.1093/jnci/djs210. Epub 2012 Apr 24.

18.

AKT/SGK-sensitive phosphorylation of GSK3 in the regulation of L-selectin and perforin expression as well as activation induced cell death of T-lymphocytes.

Bhavsar SK, Merches K, Bobbala D, Lang F.

Biochem Biophys Res Commun. 2012 Aug 17;425(1):6-12. doi: 10.1016/j.bbrc.2012.07.030. Epub 2012 Jul 16.

PMID:
22814108
19.

DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein.

An J, Yang DY, Xu QZ, Zhang SM, Huo YY, Shang ZF, Wang Y, Wu DC, Zhou PK.

Mol Cancer. 2008 Apr 22;7:32. doi: 10.1186/1476-4598-7-32.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk